307 related articles for article (PubMed ID: 18207460)
21. Overexpression of histone deacetylase 2 predicts unfavorable prognosis in human gallbladder carcinoma.
Du X; Zhao H; Zang L; Song N; Yang T; Dong R; Yin J; Wang C; Lu J
Pathol Oncol Res; 2013 Jul; 19(3):397-403. PubMed ID: 23242568
[TBL] [Abstract][Full Text] [Related]
22. Expression of histone deacetylases in diffuse large B-cell lymphoma and its clinical significance.
Lee SH; Yoo C; Im S; Jung JH; Choi HJ; Yoo J
Int J Med Sci; 2014; 11(10):994-1000. PubMed ID: 25076845
[TBL] [Abstract][Full Text] [Related]
23. Expression and prognostic analyses of HDACs in human gastric cancer based on bioinformatic analysis.
Chen L; Fei Y; Zhao Y; Chen Q; Chen P; Pan L
Medicine (Baltimore); 2021 Jul; 100(27):e26554. PubMed ID: 34232196
[TBL] [Abstract][Full Text] [Related]
24. [Prognostic factors of lymph node-negative metastasis gastric cancer].
Sun D; Xu H; Huang J
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Feb; 20(2):190-194. PubMed ID: 28226354
[TBL] [Abstract][Full Text] [Related]
25. Overexpression of HDACs: a prognostic marker for gastric cancer identified by tissue microarray.
Kanai Y
Lancet Oncol; 2008 Feb; 9(2):91-3. PubMed ID: 18237848
[No Abstract] [Full Text] [Related]
26. Dysregulated Class I histone deacetylases are indicators of poor prognosis in multiple myeloma.
Mithraprabhu S; Kalff A; Chow A; Khong T; Spencer A
Epigenetics; 2014 Nov; 9(11):1511-20. PubMed ID: 25482492
[TBL] [Abstract][Full Text] [Related]
27. Development and validation of a gene expression-based signature to predict distant metastasis in locoregionally advanced nasopharyngeal carcinoma: a retrospective, multicentre, cohort study.
Tang XR; Li YQ; Liang SB; Jiang W; Liu F; Ge WX; Tang LL; Mao YP; He QM; Yang XJ; Zhang Y; Wen X; Zhang J; Wang YQ; Zhang PP; Sun Y; Yun JP; Zeng J; Li L; Liu LZ; Liu N; Ma J
Lancet Oncol; 2018 Mar; 19(3):382-393. PubMed ID: 29428165
[TBL] [Abstract][Full Text] [Related]
28. A Decrease of Histone Deacetylase 6 Expression Caused by Helicobacter Pylori Infection is Associated with Oncogenic Transformation in Gastric Cancer.
He Q; Li G; Wang X; Wang S; Hu J; Yang L; He Y; Pan Y; Yu D; Wu Y
Cell Physiol Biochem; 2017; 42(4):1326-1335. PubMed ID: 28700998
[TBL] [Abstract][Full Text] [Related]
29. Clinicopathological significance of orphan nuclear receptor Nurr1 expression in gastric cancer.
Guo J; Zu G; Zhou T; Xing J; Wang Z
Clin Transl Oncol; 2015 Oct; 17(10):788-94. PubMed ID: 26022133
[TBL] [Abstract][Full Text] [Related]
30. Histone modifiers and marks define heterogeneous groups of colorectal carcinomas and affect responses to HDAC inhibitors in vitro.
Lutz L; Fitzner IC; Ahrens T; Geißler AL; Makowiec F; Hopt UT; Bogatyreva L; Hauschke D; Werner M; Lassmann S
Am J Cancer Res; 2016; 6(3):664-76. PubMed ID: 27152243
[TBL] [Abstract][Full Text] [Related]
31. Class 1-Selective Histone Deacetylase (HDAC) Inhibitors Enhance HIV Latency Reversal while Preserving the Activity of HDAC Isoforms Necessary for Maximal HIV Gene Expression.
Zaikos TD; Painter MM; Sebastian Kettinger NT; Terry VH; Collins KL
J Virol; 2018 Mar; 92(6):. PubMed ID: 29298886
[TBL] [Abstract][Full Text] [Related]
32. Type-specific roles of histone deacetylase (HDAC) overexpression in ovarian carcinoma: HDAC1 enhances cell proliferation and HDAC3 stimulates cell migration with downregulation of E-cadherin.
Hayashi A; Horiuchi A; Kikuchi N; Hayashi T; Fuseya C; Suzuki A; Konishi I; Shiozawa T
Int J Cancer; 2010 Sep; 127(6):1332-46. PubMed ID: 20049841
[TBL] [Abstract][Full Text] [Related]
33. Metastasis-associated protein is a predictive biomarker for metastasis and recurrence in gastric cancer.
Okugawa Y; Mohri Y; Tanaka K; Kawamura M; Saigusa S; Toiyama Y; Ohi M; Inoue Y; Miki C; Kusunoki M
Oncol Rep; 2016 Oct; 36(4):1893-900. PubMed ID: 27574100
[TBL] [Abstract][Full Text] [Related]
34. Nuclear expression of histone deacetylases and their histone modifications predicts clinical outcome in colorectal cancer.
Benard A; Goossens-Beumer IJ; van Hoesel AQ; Horati H; de Graaf W; Putter H; Zeestraten EC; Liefers GJ; van de Velde CJ; Kuppen PJ
Histopathology; 2015 Jan; 66(2):270-82. PubMed ID: 25307864
[TBL] [Abstract][Full Text] [Related]
35. Predictive test for chemotherapy response in resectable gastric cancer: a multi-cohort, retrospective analysis.
Cheong JH; Yang HK; Kim H; Kim WH; Kim YW; Kook MC; Park YK; Kim HH; Lee HS; Lee KH; Gu MJ; Kim HY; Lee J; Choi SH; Hong S; Kim JW; Choi YY; Hyung WJ; Jang E; Kim H; Huh YM; Noh SH
Lancet Oncol; 2018 May; 19(5):629-638. PubMed ID: 29567071
[TBL] [Abstract][Full Text] [Related]
36. The relationship of CD133, histone deacetylase 1 and thrombospondin-1 in gastric cancer.
Eto S; Yoshikawa K; Shimada M; Higashijima J; Tokunaga T; Nakao T; Nishi M; Takasu C; Sato H; Kurita N
Anticancer Res; 2015 Apr; 35(4):2071-6. PubMed ID: 25862862
[TBL] [Abstract][Full Text] [Related]
37. High nuclear expression levels of histone-modifying enzymes LSD1, HDAC2 and SIRT1 in tumor cells correlate with decreased survival and increased relapse in breast cancer patients.
Derr RS; van Hoesel AQ; Benard A; Goossens-Beumer IJ; Sajet A; Dekker-Ensink NG; de Kruijf EM; Bastiaannet E; Smit VT; van de Velde CJ; Kuppen PJ
BMC Cancer; 2014 Aug; 14():604. PubMed ID: 25139823
[TBL] [Abstract][Full Text] [Related]
38. SIRT1 expression is associated with a poor prognosis, whereas DBC1 is associated with favorable outcomes in gastric cancer.
Noguchi A; Kikuchi K; Zheng H; Takahashi H; Miyagi Y; Aoki I; Takano Y
Cancer Med; 2014 Dec; 3(6):1553-61. PubMed ID: 25146318
[TBL] [Abstract][Full Text] [Related]
39. Relationship between expression of IGFBP7 and clinicopathological variables in gastric cancer.
Sato Y; Inokuchi M; Takagi Y; Otsuki S; Fujimori Y; Yanaka Y; Kobayashi K; Higuchi K; Kojima K; Kawano T
J Clin Pathol; 2015 Oct; 68(10):795-801. PubMed ID: 26043748
[TBL] [Abstract][Full Text] [Related]
40. Expression of nuclear receptor corepressors and class I histone deacetylases in astrocytic gliomas.
Campos B; Bermejo JL; Han L; Felsberg J; Ahmadi R; Grabe N; Reifenberger G; Unterberg A; Herold-Mende C
Cancer Sci; 2011 Feb; 102(2):387-92. PubMed ID: 21143702
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]